DAPA MET 5/850MG TAB NEW

DAPA MET 5/850MG combines dapagliflozin and metformin to help manage type 2 diabetes effectively. This dual-action formulation works by improving insulin sensitivity and reducing blood sugar levels through multiple mechanisms. Each tablet contains 5mg dapagliflozin and 850mg metformin, providing convenient once-daily dosing for better medication adherence. Suitable for patients seeking comprehensive glycemic control with a well-established combination therapy. Always follow your healthcare provider's guidance for optimal results.